Metir PLC - Metir Secures Qatar Project Confirmation Update
23 July 2026
Metir plc
("Metir", the "Group" or the "Company")
Metir Secures Qatar Project Confirmation Update
Metir plc (AIM: MET), the global provider of fast-response, mobile, and point-of-use water and environmental monitoring technologies, is pleased to provide an update on the Group's Continuous Toxicity Monitoring ("CTM") project in Qatar , deployed by its Modern Water division.
Further to a project update meeting on 20 July 2026 involving all stakeholders, including Qatar General Electricity & Water Corporation ("Kahramaa"), Avanceon Automation & Control WLL ("Avanceon") and Modern Water, a Project Confirmation Letter ("Letter") has been received from Avanceon regarding the Group's continued performance and the project's future expansion. Modern Water is the sole supplier of its unique CTM technology.
The Letter outlines Kahramaa's and Avanceon's long-term commitment to the project and intention to progress its CTM programme with Modern Water. Following completion of the Phase 1 handover, the Group expects the contract to transition to recurring, high-margin consumables revenues while retaining the opportunity to expand the deployment through a potential second phase. The Board believes the project provides an important commercial reference installation for future CTM opportunities across the
The Letter includes:
· Confirmation by Kahramaa that the project duration is intended to continue for at least 10 years;
· a reset of the Phase 1 final project delivery milestone to
· transition of the project into its maintenance phase following final handover in
· on final handover commencement of recurring monthly consumables supply revenues for all 27 installed CTM units;
· an intention to enter a Phase 2 tender process for an additional 17 CTM systems (total 44 CTM systems installed) subject to standard procurement and tender procedures for a minimum 10-year operational period;
· support for the establishment of a local laboratory facility in
Due to the ongoing hostilities in the region, there have been, and continue to be, constraints on the shipment of bio-reagents to
The Group is pleased to report that the review and optimisation process has confirmed that there are no material instrument problems with the 27 CTM-deployed systems. The issues to resolve relate mainly to local storage, handling and performance of the Microtox® reagent under high local ambient temperatures. A specialist biochemist will be deployed by Modern Water to
Consequently, Kahramma currently expects the full Phase 1 project handover in
Microtox® CTM is a unique product that enables fully automated, real-time toxicity monitoring, providing alerts within minutes of sampling and testing. The monitoring provides a general screening (capable of detecting thousands of toxins), as a first line of defence against water contamination. The service facilitates continuous 24/7 early-warning detection of the contamination of water supplies for populations and industrial operations.
"We are pleased to have resolved the project uncertainty during a difficult period of restricted activity in the region and to have received this project confirmation update. The Board believes this reflects the progress achieved on the
The Board believes the
The project is expected to generate recurring revenue after project handover in Q4 2026 from the supply of consumables. The potential Phase 2 expansion and proposed establishment of local reagent production capability would also increase revenues from sales of CTM units and then the provision of reagents, leading on to long-term strategic and wider commercial opportunities for Metir."
- Ends -
Enquiries:
|
Metir plc |
+44 (0) 20 3657 0050 via TPI |
|
|
|
|
SPARK Advisory Partners Limite |
+44 (0)20 3368 3550 |
|
|
|
|
Turner Pope Investments (TPI) Limited Andrew Thacker / |
+44 (0) 20 3657 0050 |
|
Northstar Communications (Investor Relations) |
+44 (0) 113 730 3896 |
About Metir
Metir plc is a leading global provider of several fast-response, mobile and point-of-use water and environmental monitoring technologies. Through its two established trading divisions, Modern Water and Microsaic Systems, a specialist in mobile PFAS monitoring, the Company develops and supplies innovative, easy-to-use solutions that deliver rapid, accurate water and liquids quality results, helping industries, utilities and regulators monitor safety and compliance in real time.
With a strong focus on data-driven insight and field-ready design, Metir's technology supports critical decision-making across sectors, including environmental monitoring, public health and industrial process management.
Headquartered in
For more information, please visit: https://www.metirplc.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE